{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:18:06Z","timestamp":1787761086523,"version":"build-2784847793"},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While the presence of metastases in neuroblastoma (NB) is a well\u2010established prognostic factor, the clinical significance of dissemination patterns and tumour burden and their impact on response and survival remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterise metastatic dissemination patterns and tumour burden in NB, evaluate their response to induction therapy, and determine their prognostic impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed 53 patients with metastatic NB between 2010 and 2024 in a reference tertiary care hospital and treated as per SIOPEN protocol or standard\u2010of\u2010care recommendations. Responses were recorded as per INRC 2017. Survival was estimated using Kaplan\u2013Meier analysis, and associations between metastatic patterns and outcomes were evaluated by univariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most frequent metastatic sites were bone (77%), regional lymph nodes (64%), and bone marrow (55%). MSI (metastatic site index) was 1 (\n                      <jats:italic>n<\/jats:italic>\n                      = 13), 2 (\n                      <jats:italic>n<\/jats:italic>\n                      = 13), 3 (\n                      <jats:italic>n<\/jats:italic>\n                      = 15), or \u22654 (\n                      <jats:italic>n<\/jats:italic>\n                      = 12). Overall response according to INRC after induction therapy achieved complete (\n                      <jats:italic>n<\/jats:italic>\n                      = 1), partial (\n                      <jats:italic>n<\/jats:italic>\n                      = 41), minor (\n                      <jats:italic>n<\/jats:italic>\n                      = 6) responses, stable (\n                      <jats:italic>n<\/jats:italic>\n                      = 4) or progressive disease (\n                      <jats:italic>n<\/jats:italic>\n                      = 1). Regarding metastatic response, regional and distant lymph nodes, renal and pulmonary decreased in size by 66%, 85%, 90 and 99%, respectively. The median SIOPEN score decreased from 16.5 to 0. Bone marrow infiltration disappeared in 82%. High tumour burden strongly correlated with poor outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Presence of renal metastases, ascites, bone marrow infiltration, high tumour burden at diagnosis and post\u2010induction pulmonary or renal metastases are negative prognostic markers. Incorporating these factors into risk stratification may guide personalised treatment strategies. Future work should elucidate the genomic background and underlying causes of these different metastatic patterns.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/1545-5017.70558","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T07:33:30Z","timestamp":1784964810000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma"],"prefix":"10.1002","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5392-4894","authenticated-orcid":false,"given":"Mariona","family":"Morell\u2010Daniel","sequence":"first","affiliation":[{"name":"Paediatric Oncology and Haematology Department Hospital Vall d'Hebron, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"},{"name":"Childhood Cancer &amp; Blood Disorders Group, Vall d'Hebron Research Institute, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"},{"name":"Departamento de Medicina, Universidad Aut\u00f3noma de Barcelona, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9797-4917","authenticated-orcid":false,"given":"Santiago","family":"P\u00e9rez\u2010Hoyos","sequence":"additional","affiliation":[{"name":"Genetics, Microbiology and Statistics Department, Facultat de Biologia Universitat de Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9659-1471","authenticated-orcid":false,"given":"Aroa","family":"Soriano","sequence":"additional","affiliation":[{"name":"Childhood Cancer &amp; Blood Disorders Group, Vall d'Hebron Research Institute, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-9717","authenticated-orcid":false,"given":"Ana","family":"Coma","sequence":"additional","affiliation":[{"name":"Paediatric Radiology Department Vall d'Hebron Hospital Campus  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Varo","sequence":"additional","affiliation":[{"name":"Paediatric Oncology and Haematology Department Hospital Vall d'Hebron, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Hladun","sequence":"additional","affiliation":[{"name":"Paediatric Oncology and Haematology Department Hospital Vall d'Hebron, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-2672","authenticated-orcid":false,"given":"Gabriela","family":"Guill\u00e9n","sequence":"additional","affiliation":[{"name":"Paediatric Surgery Department Vall d'Hebron Hospital Campus  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1654-3531","authenticated-orcid":false,"given":"Soraya","family":"Mico","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department Vall d'Hebron Hospital Campus  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7762-7085","authenticated-orcid":false,"given":"Marta","family":"Garrido","sequence":"additional","affiliation":[{"name":"Department of Pathology Vall d'Hebron Hospital Campus  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Rubio","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Vall d'Hebron Hospital Campus  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6426-7423","authenticated-orcid":false,"given":"Alba","family":"Rubio\u2010San\u2010Sim\u00f3n","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology &amp; Oncology, Hospital Ni\u00f1o Jes\u00fas  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Minguez","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology &amp; Oncology, Hospital Ni\u00f1o Jes\u00fas  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-9892","authenticated-orcid":false,"given":"Ricardo","family":"L\u00f3pez\u2010Almaraz","sequence":"additional","affiliation":[{"name":"Paediatric Hemato\u2010Oncology Unit University Hospital of Cruces, BioBizkaia Health Research Institute  Barakaldo\u2010Bizkaia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Illade","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology &amp; Oncology, Hospital Cl\u00ednico Universitario de Santiago  Santiago Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-3618","authenticated-orcid":false,"given":"Miguel F.","family":"Segura","sequence":"additional","affiliation":[{"name":"Childhood Cancer &amp; Blood Disorders Group, Vall d'Hebron Research Institute, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-1670","authenticated-orcid":false,"given":"Lucas","family":"Moreno","sequence":"additional","affiliation":[{"name":"Paediatric Oncology and Haematology Department Hospital Vall d'Hebron, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"},{"name":"Childhood Cancer &amp; Blood Disorders Group, Vall d'Hebron Research Institute, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"},{"name":"Departamento de Medicina, Universidad Aut\u00f3noma de Barcelona, Instituto de Investigaci\u00f3n Sanitaria Hospital Universitari Vall d'Hebron (IIS IR\u2010HUVH)  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60983-0"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2010.03.007"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpdhp.2014.01.005"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28473"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.6785"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0177"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.8925"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411601"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20104642(25)00241\u2010X"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199905000-00005"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.02.003"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29848"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30578-3"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.06.005"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3829-7"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03011-y"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2026.01.043"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcped.2024.100193"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70558","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1545-5017.70558","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:19:03Z","timestamp":1787757543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1545-5017.70558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/1545-5017.70558"],"URL":"https:\/\/doi.org\/10.1002\/1545-5017.70558","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"2026-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70558"}}